Integrating imaging findings in evaluating the post-chemotherapy brain

Brain Imaging and Behavior

Volumn 7, Issue 4, 2013, Pages 436-452

  Pomykala, K L ^a   de Ruiter, M B ^b   Deprez, S ^c   McDonald, B C ^d   Silverman, D H S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Cognitive complaints; Diffusion tensor imaging; Functional magnetic resonance imaging; Magnetic resonance imaging; Neuroimaging; Positron emission tomography

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; THIOTEPA; UFT;

BRAIN; BRAIN FUNCTION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; COGNITIVE DEFECT; DECLARATIVE MEMORY; DIFFUSION TENSOR IMAGING; ELECTROENCEPHALOGRAPHY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SELECTIVE ATTENTION; VOXEL BASED MORPHOMETRY; WHITE MATTER; WORKING MEMORY;

ANTINEOPLASTIC AGENTS; BRAIN DISEASES; COGNITION DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS; MULTIMODAL IMAGING; NEOPLASMS; NEUROIMAGING; SYSTEMS INTEGRATION;

EID: 84901306934     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-013-9239-y     Document Type: Review

References (59)

1. Abraham, J., Haut, M. W., Moran, M. T., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008). Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clinical Breast Cancer, 8(1), 88-91. doi:10.3816/CBC.2008.n.007.
2. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. [Research Support, N.I.H., Extramural Review]. Nature Reviews. Cancer, 7(3), 192-201. doi:10.1038/nrc2073.
3. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. [Comparative Study Research Support, U.S. Gov't, P.H.S.]. Journal of Clinical Oncology, 20(2), 485-493.
4. Baudino, B., D'Agata, F., Caroppo, P., Castellano, G., Cauda, S., Manfredi, M., et al. (2012). The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 56(6), 559-568.
5. Bergouignan, L., Lefranc, J. P., Chupin, M., Morel, N., Spano, J. P., & Fossati, P. (2011). Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. [Research Support, Non-U.S. Gov't]. PLoS One, 6(10), e25349. doi:10.1371/journal.pone.0025349.
6. Burstein, H. J. (2007). Cognitive side-effects of adjuvant treatments. [Review]. Breast, 16(Suppl 2), S166-S168. doi:10.1016/ j.breast.2007.07.027.
7. Cabeza, R., & Nyberg, L. (2000). Imaging cognition II: an empirical review of 275 PET and fMRI studies. [Review]. Journal of Cognitive Neuroscience, 12(1), 1-47.
8. Chiaravalloti, A., Pagani, M., Di Pietro, B., Danieli, R., Tavolozza, M., Travascio, L., et al. (2013). Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma? Nuclear Medicine Communications, 34(1), 57-63. doi:10.1097/ MNM.0b013e32835aa7de.
9. Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., et al. (2010). Prechemotherapy alterations in brain function in women with breast cancer. [Research Support, Non-U.S. Gov't]. Journal of Clinical and Experimental Neuropsychology, 32(3), 324-331. doi:10.1080/13803390903032537.
10. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., et al. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. [Research Support, Non-U.S. Gov't]. Human Brain Mapping, 33(12), 2971-2983. doi:10.1002/hbm.21422.
11. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., vanDam, F. S., Nederveen, A. J., et al. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32(8), 1206-1219. doi:10.1002/hbm.21102.
12. Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., et al. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. [Research Support, Non-U.S. Gov't]. Journal of Clinical Oncology, 30(3), 274-281. doi:10.1200/JCO.2011.36.8571.
13. Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. [Research Support, Non-U.S. Gov't]. Human Brain Mapping, 32(3), 480-493. doi:10.1002/hbm.21033.
14. Dietrich, J., Monje, M., Wefel, J., &Meyers, C. (2008). Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. [Research Support, Non-U.S. Gov't Review]. The Oncologist, 13(12), 1285-1295. doi:10.1634/theoncologist.2008-0130.
15. Dijkstra, J. B., Houx, P. J., & Jolles, J. (1999). Cognition after major surgery in the elderly: test performance and complaints. [Research Support, Non-U.S. Gov't]. British Journal of Anaesthesia, 82(6), 867-874.
16. Dodds, C., & Allison, J. (1998). Postoperative cognitive deficit in the elderly surgical patient. [Review]. British Journal of Anaesthesia, 81(3), 449-462.
17. Eheman, C., Henley, S. J., Ballard-Barbash, R., Jacobs, E. J., Schymura, M. J., Noone, A. M., et al. (2012). Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. [Editorial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Cancer, 118(9), 2338-2366. doi:10.1002/cncr.27514.
18. Ferguson, R. J., & Ahles, T. A. (2003). Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review]. Current Neurology and Neuroscience Reports, 3(3), 215-222.
19. Ferguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007). Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. [Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Twin Study]. Journal of Clinical Oncology, 25(25), 3866-3870. doi:10.1200/JCO.2007.10.8639.
20. Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., et al. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. [Comparative Study Research Support, Non-U.S. Gov't]. Cancer, 109(1), 146-156. doi:10.1002/ cncr.22368.
21. Kesler, S., Janelsins, M., Koovakkattu, D., Palesh, O., Mustian, K., Morrow, G., et al. (2012). Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain, Behavior, and Immunity. doi:10.1016/ j.bbi.2012.05.017.
22. Kesler, S. R., Bennett, F. C., Mahaffey, M. L., & Spiegel, D. (2009). Regional brain activation during verbal declarative memory in metastatic breast cancer. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Clinical Cancer Research, 15(21), 6665-6673. doi:10.1158/1078-0432.CCR-09-1227.
23. Kesler, S. R., Kent, J. S., & O'Hara, R. (2011). Prefrontal cortex and executive function impairments in primary breast cancer. [Comparative Study Research Support, N.I.H., Extramural]. Archives of Neurology, 68(11), 1447-1453. doi:10.1001/ archneurol.2011.245.
24. Koppelmans, V., Breteler, M. M., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012a). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30(10), 1080-1086. doi:10.1200/JCO.2011.37.0189.
25. Koppelmans, V., de Ruiter, M. B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., et al. (2012b). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. [Research Support, Non-U.S. Gov't]. Breast Cancer Research and Treatment, 132(3), 1099-1106. doi:10.1007/s10549-011-1888-1.
26. Koppelmans, V., Groot, M. D., de Ruiter, M. B., Boogerd, W., Seynaeve, C., Vernooij, M. W., et al. (2012c). Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy. Human Brain Mapping. doi:10.1002/ hbm.22221.
27. Kreukels, B. P., Hamburger, H. L., de Ruiter, M. B., van Dam, F. S., Ridderinkhof, K. R., Boogerd, W., et al. (2008). ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. [Clinical Trial Research Support, Non-U.S. Gov't]. Clinical Neurophysiology, 119(3), 533-541. doi:10.1016/ j.clinph.2007.11.011.
28. Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Hamburger, H. L., Muller, M. J., et al. (2006). Effects of highdose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study. [Comparative Study Research Support, Non-U.S. Gov't]. Clinical Breast Cancer, 7(1), 67-78. doi:10.3816/ CBC.2006.n.015.
29. Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Hamburger, H. L., & van Dam, F. S. (2005). Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. [Research Support, Non-U.S. Gov't]. Breast Cancer Research and Treatment, 94(1), 53-61. doi:10.1007/s10549-005-7093-3.
30. McAllister, T.W., Saykin, A. J., Flashman, L. A., Sparling, M. B., Johnson, S. C., Guerin, S. J., et al. (1999). Brain activation during working memory 1 month after mild traumatic brain injury: a functional MRI study. [Clinical Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Neurology, 53(6), 1300-1308.
31. McAllister, T. W., Sparling, M. B., Flashman, L. A., Guerin, S. J., Mamourian, A. C., & Saykin, A. J. (2001). Differential working memory load effects after mild traumatic brain injury. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. NeuroImage, 14(5), 1004-1012. doi:10.1006/nimg.2001.0899.
32. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Breast Cancer Research and Treatment, 123(3), 819-828. doi:10.1007/s10549-010-1088-4.
33. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2012a). Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Journal of Clinical Oncology, 30(20), 2500-2508. doi:10.1200/JCO.2011.38.5674.
34. McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D., & Saykin, A. J. (2012b). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain, Behavior, and Immunity. doi:10.1016/j.bbi.2012.05.007.
35. Menon, V., Boyett-Anderson, J. M., Schatzberg, A. F., & Reiss, A. L. (2002). Relating semantic and episodic memory systems. [Clinical Trial Research Support, U.S. Gov't, P.H.S.]. Brain Research. Cognitive Brain Research, 13(2), 261-265.
36. Minisini, A., Atalay, G., Bottomley, A., Puglisi, F., Piccart, M., & Biganzoli, L. (2004). What is the effect of systemic anticancer treatment on cognitive function? The Lancet Oncology, 5(5), 273-282. doi:10.1016/s1470-2045(04)01465-2.
37. Monk, T. G., Weldon, B. C., Garvan, C. W., Dede, D. E., van der Aa, M. T., Heilman, K. M., et al. (2008). Predictors of cognitive dysfunction after major noncardiac surgery. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Anesthesiology, 108(1), 18-30. doi:10.1097/ 01.anes.0000296071.19434.1e.
38. Nelson, W. L., & Suls, J. (2013). New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors. Journal of Pain and Symptom Management. doi:10.1016/j.jpainsymman.2012.11.005.
39. Nguyen, A., Geist, C., Ganz, P. A., Castellon, S. A., Irwin, M., et al. (2012). Effects of adjuvant therapy on cerebral function during short-term and long-term memory tasks. The Journal of Nuclear Medicine, 53 (Supplemental 1)(Abstract No.1956).
40. Perry, A., & Schmidt, R. E. (2006). Cancer therapy-associated CNS neuropathology: an update and review of the literature. [Review]. Acta Neuropathologica, 111(3), 197-212. doi:10.1007/s00401-005-0023-y.
41. Pomykala, K. L., & Silverman, D. H. S. (2012). Alterations in brain structure and function after chemotherapy for cancer. Future Neurology, 7(4), 443-452.
42. Price, C. C., Garvan, C. W., & Monk, T. G. (2008). Type and severity of cognitive decline in older adults after noncardiac surgery. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Anesthesiology, 108(1), 8-17. doi:10.1097/01.anes.0000296072.02527.18.
43. Roth, R. M., Isquith, P. K., & Gioia, G. A. (2005). BRIEF-A behavior rating inventory of executive function-adult version professional manual. Lutz: Psychological Assessment Resources.
44. Saykin, A. J., Wishart, H. A., Rabin, L. A., Flashman, L. A., McHugh, T. L., Mamourian, A. C., et al. (2004). Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.]. Brain, 127(Pt 7), 1574-1583. doi:10.1093/brain/awh177.
45. Schagen, S. B., Hamburger, H. L., Muller, M. J., Boogerd, W., & van Dam, F. S. (2001). Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. [Clinical Trial Comparative StudyMulticenter Study Randomized Controlled Trial]. Journal of Neuro-Oncology, 51(2), 159-165.
46. Scherling, C., Collins, B., Mackenzie, J., Bielajew, C., & Smith, A. (2011). Pre-chemotherapy differences in visuospatial workingmemory in breast cancer patients compared to controls: an FMRI study. Frontiers in Human Neuroscience, 5, 122. doi:10.3389/fnhum.2011.00122.
47. Scherling, C., Collins, B., Mackenzie, J., Bielajew, C., & Smith, A. (2012a). Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. [Research Support, Non-U.S. Gov't]. Journal of Clinical and Experimental Neuropsychology, 34(5), 543-560. doi:10.1080/13803395.2012.666227.
48. Scherling, C., Collins, B., Mackenzie, J., Lepage, C., Bielajew, C., & Smith, A. (2012b). Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. International Journal of Biology, 4(2), 3-25. doi:10.5539/ ijb.v4n2p3.
49. Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008). Cytokines and their relationship to the symptoms and outcome of cancer. [10.1038/nrc2507]. Nature Reviews. Cancer, 8(11), 887-899.
50. Silverman, D. H., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., et al. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. [Research Support, Non-U.S. Gov't]. Breast Cancer Research and Treatment, 103(3), 303-311. doi:10.1007/s10549-006-9380-z.
51. Taillibert, S., Voillery, D., & Bernard-Marty, C. (2007). Chemobrain: is systemic chemotherapy neurotoxic? [Review]. Current Opinion in Oncology, 19(6), 623-627. doi:10.1097/CCO.0b013e3282f0e224.
52. van Dam, F. S., Schagen, S. B., Muller, M. J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M. E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. [Clinical Trial Randomized Controlled Trial]. Journal of the National Cancer Institute, 90(3), 210-218.
53. Vardy, J., Booth, C., Pond, G. R., Zhan, H., Galica, J., Dhillon, H., et al. (2007). Cytokine levels in patients with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function. Chicago: Abstract Presented at the American Society of Clinical Oncology-Poster, Patient and Survivor Care. 9070.
54. Videnovic, A., Semenov, I., Chua-Adajar, R., Baddi, L., Blumenthal, D. T., Beck, A. C., et al. (2005). Capecitabine-induced multifocal leukoencephalopathy: a report of five cases. [Case Reports]. Neurology, 65(11), 1792-1794. doi:10.1212/01.wnl.0000187313.83515.7e. discussion 1685.
55. Wager, T. D., & Smith, E. E. (2003). Neuroimaging studies of working memory: a meta-analysis. [Meta-Analysis Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S. Review]. Cognitive, Affective, & Behavioral Neuroscience, 3(4), 255-274.
56. Wefel, J. S., Kayl, A. E., & Meyers, C. A. (2004). Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. [Review]. British Journal of Cancer, 90(9), 1691-1696. doi:10.1038/sj.bjc.6601772.
57. Wefel, J. S., & Schagen, S. B. (2012). Chemotherapy-related cognitive dysfunction. Current Neurology and Neuroscience Reports, 12(3), 267-275. doi:10.1007/s11910-012-0264-9.
58. Wishart, H. A., Saykin, A. J., McDonald, B. C., Mamourian, A. C., Flashman, L. A., Schuschu, K. R., et al. (2004). Brain activation patterns associated with working memory in relapsing-remitting MS. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.]. Neurology, 62(2), 234-238.
59. Yoshikawa, E., Matsuoka, Y., Inagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., et al. (2005). No adverse effects of adjuvant chemotherapy on hippocampal volumein Japanese breast cancer survivors. Breast Cancer Research and Treatment, 92(1), 81-84. doi:10.1007/s10549-005-1412-6.